Review





Similar Products

93
Sino Biological human bmprii protein
Human Bmprii Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/Human+BMPR2+%2F+BMPR-II+Protein/us12473367-985-12-15
Average 93 stars, based on 1 article reviews
human bmprii protein - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
Bio-Techne corporation human bmpr-ii antibody
Human Bmpr Ii Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/Human+BMPR-II+Antibody/bio-techne+corporation___mab811
Average 91 stars, based on 1 article reviews
human bmpr-ii antibody - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
R&D Systems bmpr ii
Bmpr Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/Human+BMPR-IA%2FALK-3+Antibody/pmc12553006-78-3-9
Average 93 stars, based on 1 article reviews
bmpr ii - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
R&D Systems anti bmpr ii antibody
The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II <t>(BMPR-IA</t> and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody <t>and</t> <t>1:2000</t> horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.
Anti Bmpr Ii Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/Human+BMPR-II+Antibody/pmc12553006-79-14-16
Average 93 stars, based on 1 article reviews
anti bmpr ii antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti bmpr2 antibody
The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II <t>(BMPR-IA</t> and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody <t>and</t> <t>1:2000</t> horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.
Anti Bmpr2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/BMPR-II+Antibody/pm41152257-301-18-22
Average 93 stars, based on 1 article reviews
anti bmpr2 antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
R&D Systems lipolysis bmprii fc human mouse 811 br 100 r d systems spr
The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II <t>(BMPR-IA</t> and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody <t>and</t> <t>1:2000</t> horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.
Lipolysis Bmprii Fc Human Mouse 811 Br 100 R D Systems Spr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/Recombinant+Human%2FMouse+BMPR-II+Fc+Chimera+Protein%2C+CF/pmc12075709__41467_2025_59673_MOESM1_ESM-11-88-93
Average 93 stars, based on 1 article reviews
lipolysis bmprii fc human mouse 811 br 100 r d systems spr - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
EIAab Inc human bmpr-ii enzyme-linked immunosorbent assay (elisa) kits
The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II <t>(BMPR-IA</t> and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody <t>and</t> <t>1:2000</t> horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.
Human Bmpr Ii Enzyme Linked Immunosorbent Assay (Elisa) Kits, supplied by EIAab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmpr+ii/human+filaggrin+elisa+kit/pmc12059882-95-14-24
Average 90 stars, based on 1 article reviews
human bmpr-ii enzyme-linked immunosorbent assay (elisa) kits - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II (BMPR-IA and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody and 1:2000 horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.

Journal: Regenerative Therapy

Article Title: Bone morphogenetic protein-2-derived osteogenic peptide promotes bone regeneration via osteoblastogenesis

doi: 10.1016/j.reth.2025.09.006

Figure Lengend Snippet: The osteogenic signal transduction of OP5. (A) The binding affinity of the peptide to BMP receptor types IA and II (BMPR-IA and II). BMPR-IA or BMPR-II in lysate of human mesenchymal stromal cells (hMSCs) was immobilized on a microplate using a specific BMP receptor antibody in an ELISA. Data represents mean ± S.D. Binding activity of BMP-2 (2 μg/ml) and OP5 (20 μg/ml) are detected using anti-BMP-2 monoclonal antibody and 1:2000 horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG as a secondary antibody binding to primary antibody. Each bar shows the mean ± S.D. ∗ P < 0.05, ∗∗ P < 0.01. (B) Western blot analysis of β-catenin, phosphorylated cAMP response element-binding protein (P-CREB), and phosphorylated SMAD (P-SMAD) expression in hMSCs treated with BMP-2 and OP5 for 3 and 6 h. Cell lysates were prepared and analyzed by western blot using antibodies to β-catenin, P-CREB, and P-SMAD (all of 1:1000). The expression level of each group was normalized with the density % of β-actin in the same group. O.D., optical density; None, without peptide or protein group; BMP, bone morphogenetic protein; OP, osteogenic peptide; DWIVA, amino acid sequence from osteogenic peptide; 10F, 10F medium [Low-glucose Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine serum (FBS) and 1 % antibiotic/antimycotic] as the control group.

Article Snippet: The plates were then incubated overnight at 4 °C with 1:1,000 mouse anti-BMPR-IA and anti-BMPR-II antibody (R&D systems), followed by reaction with 1:2000 horseradish peroxidase (HRP)-conjugate rabbit anti-mouse IgG (catalog no. 7076; Cell Signaling Technology Inc., Danvers, MA, USA) for 30 min at room temperature.

Techniques: Transduction, Binding Assay, Enzyme-linked Immunosorbent Assay, Activity Assay, Western Blot, Expressing, Sequencing, Modification, Control